Article
Structural and functional characterization of pathogenic non- synonymous genetic mutations of human insulin-degrading enzyme by in silico methods.
CNS & neurological disorders drug targets - 1 Apr 2014
Shaik Noor A, Kaleemuddin Mohammed, Banaganapalli Babajan, Khan Fazal, Shaik Nazia S, Ajabnoor Ghada, Al-Harthi Sameer E, Bondagji Nabeel, Al-Aama Jumana Y, Elango Ramu
Abstract excerpt
Insulin-degrading enzyme (IDE) is a key protease involved in degrading insulin and amyloid peptides in human body. Several non-synonymous genetic mutations of IDE gene have been recently associated with susceptibility to both diabetes and Alzheimer's diseases. However, the consequence of these mutations on the structure of IDE protein and its substrate binding characteristics is not well elucidated. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
